The Patent Finder

Compositions and Methods for Treating Disorders Ameliorated by Muscarinic Receptor Activation

Karuna Therapeutics, Inc.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 6 of these applications claim priority to application 62/738,333, filed Sep 28, 2018. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresPatent lifetimeUsedRemainingConfidence
US 10,925,832Compositions and Methods for Treatment of Disorders Ameliorated by Muscarinic Receptor Activation
In force
 · High confidence
UsedRemaining
Karuna Therapeutics, Inc.In forceHigh confidence
US 10,933,020Compositions and Methods for Treating Disorders Ameliorated by Muscarinic Receptor Activation
In force
 · High confidence
Karuna Therapeutics, Inc.In forceHigh confidence
US 11,452,692Compositions and Methods for Treating Disorders Ameliorated by Muscarinic Receptor Activation
In force
 · Low confidence
Karuna Therapeutics, Inc.In forceLow confidence
US 11,471,413Compositions and Methods for Treating Disorders Ameliorated by Muscarinic Receptor Activation
In force
 · Low confidence
Karuna Therapeutics, Inc.In forceLow confidence
US 11,890,378Compositions and Methods for Treating Disorders Ameliorated by Muscarinic Receptor Activation
In force
 · Low confidence
Karuna Therapeutics, Inc.In forceLow confidence
US 12,558,317Compositions and Methods for Treating Disorders Ameliorated by Muscarinic Receptor Activation
In force
 · Medium confidence
Karuna Therapeutics, Inc.In forceMedium confidence
Application 17/167,714Compositions and Methods for Treating Disorders Ameliorated by Muscarinic Receptor Activation
Abandoned
Abandoned Dec 3, 2022
Karuna Therapeutics, Inc.AbandonedAbandoned Dec 3, 2022
Application 19/340,263Compositions and Methods for Treating Disorders Ameliorated by Muscarinic Receptor Activation
Pending
Not granted
Karuna Therapeutics, Inc.PendingNot granted
8 of 8 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
6 of these are in force and held by Karuna Therapeutics, Inc..
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited